Visionary Wealth Advisors bought a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB – Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 1,957 shares of the company’s stock, valued at approximately $945,000.
Other hedge funds have also recently modified their holdings of the company. Reflection Asset Management bought a new stake in shares of Astera Labs during the 4th quarter worth approximately $25,000. Keating Financial Advisory Services Inc. purchased a new stake in Astera Labs in the second quarter worth $25,000. Smartleaf Asset Management LLC lifted its position in shares of Astera Labs by 422.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after purchasing an additional 152 shares during the last quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA purchased a new stake in shares of Astera Labs during the fourth quarter valued at $33,000. Finally, Whipplewood Advisors LLC boosted its stake in shares of Astera Labs by 15,950.0% during the first quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock valued at $35,000 after purchasing an additional 319 shares during the period. Institutional investors own 60.47% of the company’s stock.
Astera Labs Stock Down 2.6%
Shares of Astera Labs stock opened at $277.53 on Tuesday. The firm’s 50 day moving average price is $350.46 and its 200-day moving average price is $246.41. The company has a market cap of $48.15 billion, a P/E ratio of 137.39 and a beta of 3.84. Astera Labs, Inc. has a 52-week low of $97.89 and a 52-week high of $499.48.
Insiders Place Their Bets
In related news, Director Stefan A. Dyckerhoff sold 8,994 shares of Astera Labs stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $450.00, for a total transaction of $4,047,300.00. Following the completion of the sale, the director owned 4,631 shares of the company’s stock, valued at $2,083,950. The trade was a 66.01% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 90,630 shares of Astera Labs stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the sale, the chief executive officer directly owned 1,266,665 shares of the company’s stock, valued at $431,109,432.75. This trade represents a 6.68% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last quarter, insiders have sold 419,244 shares of company stock valued at $163,135,169. Corporate insiders own 10.40% of the company’s stock.
Analyst Upgrades and Downgrades
Several research analysts recently commented on the stock. Citigroup reaffirmed a “buy” rating on shares of Astera Labs in a research note on Wednesday, July 29th. Northland Securities upgraded shares of Astera Labs from a “market perform” rating to an “outperform” rating and set a $350.00 target price on the stock in a research note on Monday, August 17th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Astera Labs in a research report on Tuesday, August 18th. Susquehanna lifted their price target on shares of Astera Labs from $230.00 to $275.00 and gave the company a “neutral” rating in a research note on Friday, July 31st. Finally, Barclays boosted their price target on Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a report on Monday, July 20th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and eight have assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $333.00.
Astera Labs Company Profile
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Featured Articles
- Five stocks we like better than Astera Labs
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
